Compounds > 1-o-hexyl-2,3,5-trimethylhydroquinone
Page last updated: 2024-09-03

1-o-hexyl-2,3,5-trimethylhydroquinone and Fatty Liver, Nonalcoholic

1-o-hexyl-2,3,5-trimethylhydroquinone has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ahn, SB; Hong, JM; Jun, DW; Kang, JK; Kang, S; Kim, GS; Kim, H; Kim, HY; Oh, JH; Saeed, WK1

Other Studies

1 other study(ies) available for 1-o-hexyl-2,3,5-trimethylhydroquinone and Fatty Liver, Nonalcoholic

ArticleYear
BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal model.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:11

    Topics: Animals; Antioxidants; Fibrosis; Hep G2 Cells; Hepatic Stellate Cells; Humans; Hydroquinones; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease

2021